Drug Company to Sell Hepatitis C Drug in India For $82,200 Less Per Regimen Than in the U.S.
Yep, you read that title right:
Sofosbuvir, the wonder medicine for Hepatitis C that costs $84,000 … for a 24-week treatment regimen in the US, will soon be available in India for about $1,800 … for the same regimen. The patent holder, pharma major Gilead, announced on Monday that it would be selling the drug at this price in India and also giving voluntary licences to seven Indian pharma companies to produce it.
This is outrageous and it’s where we need government regulation where there is none. This is extortion thinly disguised as capitalism but also looking a whole lot like raw greed.